Social Media

See the latest interactions from our social media


Michael Cioffi (Vice President, Project Management) is presenting the keynote address at next weeks ...

View Post

Featured News

Read the latest updates from our PR department

PRA Health Sciences Files for Initial Public Offering

08 September 2014, Raleigh, N.C. PRA Health Sciences, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC)...

PRA Health Sciences Expands in Pennsylvania

26 August 2014, Blue Bell, PA – Blue Bell, Pennsylvania will soon be home to PRA Health Sciences’ largest office worldwide. PRA, a leading global Contract Research Organization (CRO), is...

PRA Advances to Become PRA Health Sciences

16 June 2014, RALEIGH, NC – PRA, a leading clinical research organization, today announced that it has changed its name to PRA Health Sciences (PRA). The name change to PRA Health Sciences...

Read More >

Media Resources

Explore the latest resources uploaded to our media library

Sign Up for PRA's Industry Watch

Brought to you by PRA Health Sciences. A Bi-Weekly Industry Watch Newsletter

The Fight Against Alzheimer’s Disease
September 8, 2014

US prevalence of Alzheimer’s Disease is currently at 5 million sufferers and is set to triple by 2050.

Engaging Clinical Trial Sites: The Role of the Clinical Trial Liaison
September 1, 2014

The ability to engage customers is a primary driver of business success because fully engaged customers tend to purchase more and are overall more profitable than those who are less engaged (Dasu & Chase, 2013).

Human ADME and Studies with Radiolabeled Compounds: Phase I-IIa
September 1, 2014

Radiolabeled medication is widely used in the assessment of human ADME and also increasingly in assessing absolute bioavailability (BA). Conducting an ADME study early in the clinical development program—generally before or in parallel with Phase IIa—is prudent since the outcome may generate the need for additional toxicology studies.

Strategic Solutions Division: Capabilities & Expertise
September 1, 2014

We deliver clinical development services you need through customized Embedded Solutions™ designed to manage large and mid-size biopharmaceutical companies’ pipeline portfolios more efficiently and with greater flexibility and control.


Find out what's happening next on PRA's event schedule

September 10

Prepare for the future drug safety landscape at the 7th annual World Drug Safety Congress Europe. Embrace key aspects of pharmacovigilance, signal detection, clinical safety, regulations and benefit risk management and take valuable insights back to your company. Speaker: Josee Moon (Senior Safety Scientist) Presentation: Collection of Safety Data Through EDC systems: Challenges & Solutions

September 16

Partnerships in Clinical Trials Asia is an annual event that brings together 150+ global and regional pharma, biotech, CROs, regulators and clinical trial solution providers to network, learn, strategize and advance next practices in clinical trials in the region and forge more effective partnerships. Speaker: James Pusey (President & General Manager – WuXiPRA) Presentation: Clinical […]

September 28

The Society for Clinical Data Management is a non-profit, international organization of 2,400+ members dedicated to promoting quality and excellence in data management through professional development, education and certification. Speakers: Claire M. Gray (Lead Clinical Data Manager), Kate Soloman (Clinical Data Manager), Maria Fassano (Clinical Informatics Manager) Presentations: The Cooperation of CDM with Other Functions: Making It […]

Read More >